Bellerophon Therapeutics, Inc.·4

Sep 13, 8:21 PM ET

Bellerophon Therapeutics, Inc. 4

4 · Bellerophon Therapeutics, Inc. · Filed Sep 13, 2016

Insider Transaction Report

Form 4
Period: 2016-09-12
Quinn Deborah
Chief Medical Officer
Transactions
  • Tax Payment

    Common Stock

    2016-09-12$1.38/sh18,548$25,59631,244 total

Documents

1 file
  • 4
    wf-form4_147381248185764.xmlPrimary

    FORM 4